Futuro da Saúde
by Futuro da Saúde
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇧🇷BR · Health & Fitness#1921K to 10K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
500 to 5K🎙 ~2x weekly·158 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
1K to 10K🇧🇷100% - Active Followers
Loyal subscribers who consistently listen
300 to 3K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 19 epsHost
Recent guests
Recent episodes
Soberania farmacêutica no Brasil [Norberto Prestes, presidente da Abiquifi] – Futuro Talks #96
Jul 13, 2026
1h 04m 20s
Futuro Talks #95 - Participação social nas decisões de saúde [Catherine Moura, CEO da Abrale]
Jun 29, 2026
1h 04m 20s
Futuro Talks Ed. Especial - Inovação e estratégia em rede [Gustavo Pinto, diretor na Rede Américas]
Jun 24, 2026
35m 06s
Pensando no Futuro #19 - ASCO 2026: destaques da oncologia
Jun 18, 2026
48m 59s
Futuro Talks #94 - Integração de dados e eficiência na saúde [Paulo Magnus, CEO da MV]
Jun 15, 2026
1h 00m 33s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/13/26 | soberania farmacêuticainsumos farmacêuticos+3 | Norberto Prestes | Associação Brasileira da Indústria de Insumos Farmacêuticos | — | soberaniaIFAs+4 | Grupo Fleury | 1h 04m 20s | ||
| 6/29/26 | oncologypublic health policy+4 | Catherine Moura | Associação Brasileira de Linfoma e LeucemiaMovimento Todos Juntos Contra o Câncer | — | oncologypublic health+5 | Grupo Fleury | 1h 04m 20s | ||
| 6/24/26 | inovaçãointeligência artificial+3 | Gustavo Pinto | Rede Américas | São Paulo | inovaçãointeligência artificial+5 | Siemens Healthineers | 35m 06s | ||
| 6/18/26 | oncologypersonalized medicine+4 | Ana Paula CardosoGustavo Schwartsman+1 | Sociedade Americana de Oncologia Clínica | Chicago | oncologyASCO 2026+5 | — | 48m 59s | ||
| 6/15/26 | digitalizaçãosaúde+4 | Paulo Magnus | MV | — | digitalizaçãosaúde+4 | Grupo Fleury | 1h 00m 33s | ||
| 6/1/26 | medicamentos GLP-1tratamento da obesidade+4 | Andressa Heimbecher Soares | semaglutidatirzepatida | — | GLP-1análogos de GLP-1+5 | Grupo Fleury | 59m 13s | ||
| 5/29/26 | oncologyteranostics+4 | Clarissa Mathias | Hospital Santa IzabelOncoclínicas | São Paulo, SP | oncologyteranostics+5 | Siemens Healthineers | 23m 31s | ||
| 5/29/26 | inteligência artificialradiologia+5 | Giovanni Cerri | InRadICOS+1 | — | radiologiainteligência artificial+5 | Siemens Healthineers | 37m 58s | ||
| 5/18/26 | terapias oncológicasindústria farmacêutica+3 | Christiano Silva | BMS | — | terapias oncológicasindústria farmacêutica+3 | Grupo Fleury | 1h 08m 27s | ||
| 5/4/26 | Anvisahealth innovation+3 | Leandro Safatle | Anvisa | — | Anvisahealth+5 | Grupo Fleury | 1h 12m 38s | ||
| 4/20/26 | indústria farmacêuticaacesso à saúde+3 | Andrea Sambati | Boehringer Ingelheim | — | indústria farmacêuticaacesso+5 | Grupo Fleury | 1h 04m 30s | ||
| 4/16/26 | uso de telasobesidade infantil+4 | Albert BoussoBeatriz Casella | Einstein | — | telasobesidade+4 | — | 54m 00s | ||
| 4/6/26 | saúde suplementarsustentabilidade+3 | Sami Foguel | Porto Saúde | — | saúdeplanos de saúde+3 | Grupo Fleury | 57m 31s | ||
| 3/26/26 | cardiologyprecision medicine+3 | Pedro LemosMarcelo Franken+1 | Einstein | — | cardiologyprecision medicine+3 | — | 34m 56s | ||
| 3/23/26 | autonomyend of life+3 | Luciana Dadalto | Eu Decido | — | end of lifeautonomy+4 | Grupo Fleury | 1h 04m 24s | ||
| 3/9/26 | cancerpublic health policy+4 | Angélica Nogueira | Sociedade Brasileira de Oncologia Clínica | — | cancerpublic health+5 | Grupo Fleury | 1h 00m 46s | ||
| 3/4/26 | neurologyneuroimaging+4 | Polyana PizaEdson Amaro | EinsteinFuturo da Saúde+1 | Brasil | neurologyParkinson+5 | — | 48m 08s | ||
| 2/25/26 | terapias domiciliaresdoenças raras+4 | Rafael FreixoAntoine Daher | LEK ConsultingCasa Hunter+2 | — | terapias avançadasacesso a terapias+4 | RocheM-BR-00023542 | 51m 24s | ||
| 2/23/26 | gestão hospitalartransformação do setor hospitalar+3 | Fernando Ganem | Hospital Sírio-Libanês | — | gestão hospitalareficiência+3 | Grupo Fleury | 1h 05m 57s |
Showing 19 of 19
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Futuro da Saúde
Peaked at #192 in Brazil, currently #192 in Brazil.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Brazil | — | #192 | #192 | — |
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.